Thank you for your interest in viewing the Research Update from Steve Perrin, Ph.D. (CEO/CSO of ALS TDI) webinar!
May 16, 2018
This webinar will feature a conversation with Steve Perrin, PhD, the CEO and CSO of the ALS Therapy Development Institute. Dr. Perrin will lead the discussion on various topics and answer questions.
Please provide the following information so we can continue to make our Webinars relevant for the entire ALS community
* = Required Fields
Register now for our upcoming webinar on May 10th at 6pm: FDA approves Radicava - What do we need to know?
#WHATWOULDYOUGIVE to #ENDALS?
For ALS Awareness Month, join our #InThreeWords campaign on social media.
You can be a hero and give to ALS TDI to help us get more promising treatments out of our lab and into people living with ALS.
November 27 is
You've taken the challenge, now help
move promising treatments out of our
lab and into people living with ALS.
The 2018 Combined Federal Campaign has officially launched!
Help us continue to move more potential treatments into the clinic!
Stay up to date with ALS TDI by subscribing to our newsletter today!
Join the Ride to #EndALS